These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

365 related articles for article (PubMed ID: 5151318)

  • 21. [Clinical significance of the study of antibodies and complement in chronic hepatopathies].
    Naccarato R; Farini R; Chiaramonte M
    Minerva Med; 1978 Aug; 69(38):2573-9. PubMed ID: 309566
    [No Abstract]   [Full Text] [Related]  

  • 22. [Australia antigen and hepatic diseases (experience in Saint Louis)].
    Auger C; Diebolt G; Linhard J
    Bull Soc Med Afr Noire Lang Fr; 1973; 18(3):417-21. PubMed ID: 4206283
    [No Abstract]   [Full Text] [Related]  

  • 23. Australia antigen in liver disease in Zambia.
    Lowenthal M; Banatvala JE; Chrystie IL; Jones IG; Nag J; Mohelsky V; Hutt MS
    Trop Geogr Med; 1973 Mar; 25(1):39-44. PubMed ID: 4348424
    [No Abstract]   [Full Text] [Related]  

  • 24. [Australia antigen and humoral and cellular immunity in the acute phase of viral hepatitis].
    Farini R; Fagiolo U; Chiaramonte M; Naccarato R
    G Mal Infett Parassit; 1971 Dec; 23(12):1116-9. PubMed ID: 5004896
    [No Abstract]   [Full Text] [Related]  

  • 25. [Australia-SH antigen isolation in patients with liver disease].
    Kaboth U; Schober A; Arndt HJ; Vido I; Creutzfeldt W
    Bibl Haematol; 1971; 37():245-50. PubMed ID: 5138911
    [No Abstract]   [Full Text] [Related]  

  • 26. [Detection of Australia antigen and of the corresponding antibody in viral hepatitis and in liver cirrhosis].
    Geffroy Y; Colin R; Paillot B; Segrestin M
    Arch Fr Mal App Dig; 1971 Dec; 60(12):673-5. PubMed ID: 5158158
    [No Abstract]   [Full Text] [Related]  

  • 27. [Incidence of HBAg in various liver diseases (comparison between radioimmunologic methods and methods of passive hemagglutination)].
    Claar GM; Alvaro MC; Ascione A; De Bellis G; Sodano S; Varone GL
    Quad Sclavo Diagn; 1975 Jun; 11(2):561-6. PubMed ID: 1223959
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Aggressive chronic hepatitis and non-alcoholic cirrhosis of moderate activity and immunosuppressive treatment].
    de Groote J; Fevery J; Vandenbroucke J
    Arch Fr Mal App Dig; 1971 Dec; 60(12):664-9. PubMed ID: 5158156
    [No Abstract]   [Full Text] [Related]  

  • 29. [Significance of the presence of Australia antigen in liver diseases seen in a department of internal medicine in Abidjan].
    Soubeyrand J; Ticolat R; Leleu JP; Condat JM; Niamkey E; Diallo D; Manlan KL; Ouattara D; Beda BY
    Sem Hop; 1982 Dec; 58(46):2702-8. PubMed ID: 6297069
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Detection of Australia antigen (Au) in the serum of patients with infectious hepatitis].
    Fekete B; Münnich D; Csinády G
    Orv Hetil; 1972 May; 113(19):1103-5. PubMed ID: 5023744
    [No Abstract]   [Full Text] [Related]  

  • 31. [Hepatitis-associated antigen, Australia-SH-antigen].
    Reinicke V
    Ugeskr Laeger; 1970 May; 132(19):863-7. PubMed ID: 4246465
    [No Abstract]   [Full Text] [Related]  

  • 32. [Australia antigen and autoantibodies in chronic liver diseases].
    Müller R; Kalden J; Deicher H
    Verh Dtsch Ges Inn Med; 1972; 78():926-8. PubMed ID: 4665781
    [No Abstract]   [Full Text] [Related]  

  • 33. [Clinical and epidemiological importance of determining Australia antigen].
    Khazanov AI; Perova SD; Poliakova II; Baturova RS
    Voen Med Zh; 1974 Sep; (9):58-60. PubMed ID: 4218675
    [No Abstract]   [Full Text] [Related]  

  • 34. [The incidence of hepatitis B antigen subtypes in acute hepatitis and chronic liver diseases].
    Büki B; Szalay F; Nagylucskay S; Schvaáb E
    Orv Hetil; 1975 Jul; 116(27):1567-9. PubMed ID: 1143846
    [No Abstract]   [Full Text] [Related]  

  • 35. Localization of hepatitis B surface antigen in conventional paraffin sections of the liver. Comparison of immunofluorescence, immunoperoxidase, and orcein staining methods with regard to their specificity and reliability as antigen marker.
    Nayak NC; Sachdeva R
    Am J Pathol; 1975 Dec; 81(3):479-92. PubMed ID: 55076
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Liver disease in Japan.
    Koizumi T; Kamada T; Akiyama T
    Br Med J; 1971 Oct; 4(5779):117. PubMed ID: 5097415
    [No Abstract]   [Full Text] [Related]  

  • 37. Australia antigen in liver tissue--an immunofluorescent and immunoelectron microscopic study.
    Shikata T
    Jpn J Exp Med; 1973 Aug; 43(4):231-45. PubMed ID: 4354081
    [No Abstract]   [Full Text] [Related]  

  • 38. [Australia antigen, immunoglobulins and glycoproteins in chronic liver diseases].
    Fehér J; Jakab L; Szilvási I
    Orv Hetil; 1973 Oct; 114(42):2528-31. PubMed ID: 4743664
    [No Abstract]   [Full Text] [Related]  

  • 39. [Pathogenetic aspects of immunoglobulins of HAA positive and HAA negative liver diseases (author's transl)].
    Reis HE; Bertrams J; Kuwert E; Selmair H; Wiese W
    Med Klin; 1974 Sep; 69(39):1579-86. PubMed ID: 4456161
    [No Abstract]   [Full Text] [Related]  

  • 40. [Autoimmune reaction of the 'Chişiu type" in chronic liver diseases].
    Costică II; Dumitriu M; Benea F
    Med Interna (Bucur); 1973 Jun; 25(6):693-7. PubMed ID: 4793940
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.